المؤلفون: Jirovec, Elise, Quixabeira, Dafne C.A., Clubb, James H.A., Pakola, Santeri A., Kudling, Tatiana, Arias, Victor, Haybout, Lyna, Jalkanen, Katriina, Alanko, Tuomo, Monberg, Tine, Khammari, Amir, Dreno, Brigitte, Svane, Inge Marie, Block, Matthew S., Adamo, Daniel A., Mäenpää, Johanna, Kistler, Claudia, Sorsa, Suvi, Hemminki, Otto, Kanerva, Anna, Santos, João M., Cervera-Carrascon, Victor, Hemminki, Akseli

المساهمون: Tampere University, Children's and Women's health, Diagnostic Medicine, Psychiatry, TAYS Cancer Centre

مصطلحات موضوعية: 3122 Cancers

وصف الملف: fulltext

Relation: 297; 43; https://trepo.tuni.fi/handle/10024/161860

الاتاحة: https://trepo.tuni.fi/handle/10024/161860
https://doi.org/10.1186/s13046-024-03219-0

المؤلفون: Basnet, Saru, Van der Heijden, Mirte, Quixabeira, Dafne C.A., Jirovec, Elise, Grönberg-Vähä-Koskela, Susanna A.M., Clubb, James H.A., Kanerva, Anna, Pakola, Santeri, Haybout, Lyna, Arias, Victor, Hemminki, Otto, Kudling, Tatiana, Zafar, Sadia, Cervera-Carrascon, Victor, Santos, Joao M., Hemminki, Akseli

المصدر: Molecular Therapy ; volume 32, issue 8, page 2800 ; ISSN 1525-0016

الاتاحة: https://doi.org/10.1016/j.ymthe.2024.07.009
https://api.elsevier.com/content/article/PII:S1525001624004647?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S1525001624004647?httpAccept=text/plain

المؤلفون: Basnet, Saru, Santos, Joao M., Quixabeira, Dafne C.A., Clubb, James H.A., Grönberg-Vähä-Koskela, Susanna A.M., Arias, Victor, Pakola, Santeri, Kudling, Tatiana V., Heiniö, Camilla, Havunen, Riikka, Cervera-Carrascon, Victor, Sorsa, Suvi, Anttila, Marjukka, Kanerva, Anna, Hemminki, Akseli

المساهمون: orcid:0000-0003-4089-1357, Ruokavirasto, Finnish Food Authority

مصطلحات موضوعية: cancerous diseases, oncolytic viruses, adenoviruses, immunotherapy

وصف الملف: 59-73; application/pdf

Relation: Molecular Therapy - Oncolytics; 28; 94498; http://hdl.handle.net/10138/569414; URN:NBN:fi-fe202401051623

الاتاحة: http://hdl.handle.net/10138/569414

المؤلفون: Clubb, James H. A., Kudling, Tatiana V., Girych, Mykhailo, Haybout, Lyna, Pakola, Santeri, Hamdan, Firas, Cervera-Carrascon, Víctor, Hemmes, Annabrita, Grönberg-Vähä-Koskela, Susanna, Santos, João Manuel, Quixabeira, Dafne C. A., Basnet, Saru, Heiniö, Camilla, Arias, Victor, Jirovec, Elise, Kaptan, Shreyas, Havunen, Riikka, Sorsa, Suvi, Erikat, Abdullah, Schwartz, Joel, Anttila, Marjukka, Aro, Katri, Viitala, Tapani, Vattulainen, Ilpo, Cerullo, Vincenzo, Kanerva, Anna, Hemminki, Akseli

المساهمون: orcid:0000-0003-4089-1357, Ruokavirasto, Finnish Food Authority

مصطلحات موضوعية: adenoviruses, immunotherapy, oncolytic viruses

وصف الملف: application/pdf

Relation: Frontiers in Immunology; 14; 94496; http://hdl.handle.net/10138/569413; URN:NBN:fi-fe202401051620

الاتاحة: http://hdl.handle.net/10138/569413

المؤلفون: Kudling, Tatiana V, Clubb, James, Pakola, Santeri A, Quixabeira, Dafne Alves, Lähdeniemi, Iris, Heiniö, Camilla, Arias, Victor, Grönberg-Vähä-Koskela, Susanna AM, Havunen, Riikka, Cervera-Carrascon, Victor, Santos, Joao Manuel, Sutinen, Eva, Räsänen, Jari, Borenius, Kristian, Mäyränpää, Mikko, Altonen, Eero, Sorsa, Suvi, Hemminki, Otto, Kanerva, Anna, Verschuren, Emmy W, Ilonen, Ilkka, Hemminki, Akseli

المصدر: Regular and Young Investigator Award Abstracts ; page A912-A912

الاتاحة: http://dx.doi.org/10.1136/jitc-2023-sitc2023.0814
https://syndication.highwire.org/content/doi/10.1136/jitc-2023-SITC2023.0814

المؤلفون: Basnet, Saru, Heijden, Mirte Van der, Jirovec, Elise, Clubb, James, Grönberg-Vähä-Koskela, Susanna AM, Arias, Victor, Pakola, Santeri A, Kanerva, Anna, Quixabeira, Dafne Alves, Santos, Joao Manuel, Haybout, Lyna, Kudling, Tatiana, Hemminki, Akseli

المصدر: Regular and Young Investigator Award Abstracts ; page A904-A904

الاتاحة: http://dx.doi.org/10.1136/jitc-2023-sitc2023.0806
https://syndication.highwire.org/content/doi/10.1136/jitc-2023-SITC2023.0806

المؤلفون: Clubb, James H. A., Kudling, Tatiana V., Girych, Mykhailo, Haybout, Lyna, Pakola, Santeri, Hamdan, Firas, Cervera-Carrascon, Víctor, Hemmes, Annabrita, Grönberg-Vähä-Koskela, Susanna, Santos, João Manuel, Quixabeira, Dafne C. A., Basnet, Saru, Heiniö, Camilla, Arias, Victor, Jirovec, Elise, Kaptan, Shreyas, Havunen, Riikka, Sorsa, Suvi, Erikat, Abdullah, Schwartz, Joel, Anttila, Marjukka, Aro, Katri, Viitala, Tapani, Vattulainen, Ilpo, Cerullo, Vincenzo, Kanerva, Anna, Hemminki, Akseli

المصدر: Clubb , J H A , Kudling , T V , Girych , M , Haybout , L , Pakola , S , Hamdan , F , Cervera-Carrascon , V , Hemmes , A , Grönberg-Vähä-Koskela , S , Santos , J M , Quixabeira , D C A , Basnet , S , Heiniö , C , Arias , V , Jirovec , E , Kaptan , S , Havunen , R , Sorsa , S , Erikat , A , Schwartz , J , Anttila , M , Aro , K , Viitala , T , Vattulainen ....

مصطلحات موضوعية: PDAC, Syrian hamster, adenovirus, artificial intelligence, immune checkpoint inhibitor, immunotherapy, molecular simulations, oncolytic virus, /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being, name=SDG 3 - Good Health and Well-being

الاتاحة: https://cris.vtt.fi/en/publications/011bcc08-ad08-460a-b682-963c7f974200
https://doi.org/10.3389/fimmu.2023.1060540
http://www.scopus.com/inward/record.url?scp=85148512770&partnerID=8YFLogxK

المؤلفون: Kudling, Tatiana V., Clubb, James H.A., Pakola, Santeri, Quixabeira, Dafne C.A., Lähdeniemi, Iris A.K., Heiniö, Camilla, Arias, Victor, Havunen, Riikka, Cervera-Carrascon, Victor, Santos, Joao M., Sutinen, Eva, Räsänen, Jari, Borenius, Kristian, Mäyränpää, Mikko I., Aaltonen, Eero, Sorsa, Suvi, Hemminki, Otto, Kanerva, Anna, Verschuren, Emmy W., Ilonen, Ilkka, Hemminki, Akseli

المساهمون: TRIMM - Translational Immunology Research Program, Research Programs Unit, University of Helsinki, Lung Cancer Model Systems, Institute for Molecular Medicine Finland, Helsinki Institute of Life Science HiLIFE, Digital Precision Cancer Medicine (iCAN), HUS Comprehensive Cancer Center, CAN-PRO - Translational Cancer Medicine Program, HUS Heart and Lung Center, Department of Medicine, INDIVIDRUG - Individualized Drug Therapy, Keuhkosairauksien yksikkö, III kirurgian klinikka, HUSLAB, Department of Pathology, Medicum, Clinicum, HUS Abdominal Center, Urologian yksikkö, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Department of Obstetrics and Gynecology, Research Group Verschuren Emmy, Department of Surgery, Department of Oncology

مصطلحات موضوعية: adenovirus, checkpoint inhibitors, Immunotherapy, intravenous administration, Cancers

وصف الملف: application/pdf

Relation: This study was supported by the Doctoral Program in Clinical Research (University of Helsinki), Jane and Aatos Erkko Foundation, Finnish Cultural Foundation, Ida Montinin Foundation, Orion Foundation, K. Albin Johansson Foundation, HUCH Research Funds (VTR), Finnish Cancer Organizations, Sigrid Juselius Foundation, Novo Nordisk Foundation, Päivikki and Sakari Sohlberg Foundation, Finnish Red Cross Blood Service, and TILT Biotherapeutics Ltd. This study received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Marie Skłodowska-Curie grant agreement No 813453. We thank Albert Ehrnrooth and Karl Fazer for their support. Part of this work was carried out with the support of the HiLIFE Laboratory Animal Center Core Facility, University of Helsinki. We thank Minna Oksanen and Susanna Grönberg-Vähä-Koskela for expert experimental and administrative assistance. We also thank Mikko Räsänen, Lotta Ahlfors and Laboratory Animal Center (LAC, University of Helsinki, Helsinki, Finland), Biomedicum Flow Cytometry Unit (University of Helsinki, Helsinki, Finland) and Biomedicum Imaging Unit (University of Helsinki, Helsinki, Finland). Open access funded by the Helsinki University Library (University of Helsinki, Finland). We thank Minna Oksanen and Susanna Grönberg-Vähä-Koskela for expert experimental and administrative assistance. We also thank Mikko Räsänen, Lotta Ahlfors and Laboratory Animal Center (LAC, University of Helsinki, Helsinki, Finland), Biomedicum Flow Cytometry Unit (University of Helsinki, Helsinki, Finland) and Biomedicum Imaging Unit (University of Helsinki, Helsinki, Finland). Open access funded by the Helsinki University Library (University of Helsinki, Finland).; Kudling , T V , Clubb , J H A , Pakola , S , Quixabeira , D C A , Lähdeniemi , I A K , Heiniö , C , Arias , V , Havunen , R , Cervera-Carrascon , V , Santos , J M , Sutinen , E , Räsänen , J , Borenius , K , Mäyränpää , M I , Aaltonen , E , Sorsa , S , Hemminki , O , Kanerva , A , Verschuren , E W , Ilonen , I & Hemminki , A 2023 , ' Effective intravenous delivery of adenovirus armed with TNFα and IL-2 improves anti-PD-1 checkpoint blockade in non-small cell lung cancer ' , OncoImmunology , vol. 12 , no. 1 , 2241710 . https://doi.org/10.1080/2162402X.2023.2241710; ORCID: /0000-0002-0877-9640/work/141186180; ORCID: /0000-0001-5771-9129/work/141186273; ORCID: /0000-0001-6235-8612/work/141186428; ORCID: /0000-0002-8149-3550/work/141186513; ORCID: /0000-0001-6684-3666/work/141186990; ORCID: /0000-0001-7103-8530/work/156151368; http://hdl.handle.net/10138/564127; c5174aed-f4ea-45ba-b96a-b555b27737ce; 85166781615; 001041332800001

الاتاحة: http://hdl.handle.net/10138/564127

المؤلفون: Hemminki, Kari, Foersti, Asta, Liska, Vaclav, Kanerva, Anna, Hemminki, Otto, Hemminki, Akseli

المساهمون: Research Programs Unit, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Clinicum, University of Helsinki, TRIMM - Translational Immunology Research Program, Department of Obstetrics and Gynecology, HUS Abdominal Center, Urologian yksikkö, Department of Oncology, HUS Comprehensive Cancer Center

مصطلحات موضوعية: Early diagnosis, Periodic survival, Prognosis, Relative survival, Treatment, Cancers

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10138/356334; 85146320476; 000915934600001

الاتاحة: http://hdl.handle.net/10138/356334

المؤلفون: Murumägi, Astrid, Ungureanu, Daniela, Khan, Suleiman, Arjama, Mariliina, Välimäki, Katja, Ianevski, Aleksandr, Ianevski, Philipp, Bergstrom, Rebecka, Dini, Alice, Kanerva, Anna, Koivisto-Korander, Riitta, Tapper, Johanna, Lassus, Heini, Loukovaara, Mikko, Mägi, Andrus, Hirasawa, Akira, Aoki, Daisuke, Pietiäinen, Vilja, Pellinen, Teijo, Butzow, Ralf, Aittokallio, Tero, Kallioniemi, Olli

المساهمون: Institute for Molecular Medicine Finland, Precision Systems Medicine, University of Helsinki, Helsinki Institute of Life Science HiLIFE, ATG - Applied Tumor Genomics, Research Programs Unit, Department of Computer Science, Computational Systems Medicine, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Clinicum, Department of Obstetrics and Gynecology, Digital Precision Cancer Medicine (iCAN), Department of Pathology, HUSLAB, Helsinki Institute for Information Technology, Tero Aittokallio / Principal Investigator, Bioinformatics

مصطلحات موضوعية: Reprogrammed cells, Sensitivity, Resistant, Cancers

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10138/355840; 85143406376; 000894989800004

الاتاحة: http://hdl.handle.net/10138/355840

المؤلفون: Pikkusaari, Sanna, Tumiati, Manuela, Virtanen, Anni, Oikkonen, Jaana, Li, Yilin, Perez-Villatoro, Fernando, Muranen, Taru, Salko, Matilda, Huhtinen, Kaisa, Kanerva, Anna, Koskela, Heidi, Tapper, Johanna, Koivisto-Korander, Riitta, Joutsiniemi, Titta, Haltia, Ulla-Maija, Lassus, Heini, Hautaniemi, Sampsa, Färkkilä, Anniina, Hynninen, Johanna, Hietanen, Sakari, Carpen, Olli, Kauppi, Liisa

المساهمون: Research Program in Systems Oncology, Research Programs Unit, HUSLAB, Department of Pathology, Clinicum, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Department of Obstetrics and Gynecology, Sampsa Hautaniemi / Principal Investigator, Faculty Common Matters (Faculty of Medicine), Bioinformatics, Department of Biochemistry and Developmental Biology, Digital Precision Cancer Medicine (iCAN), Precision Cancer Pathology, Olli Mikael Carpen / Principal Investigator, HUS Diagnostic Center, Medicum, Faculty Common Matters (Faculty of Biology and Environmental Sciences), Genome Stability Group

مصطلحات موضوعية: Somatic mutations, Double-blind, Platinum, Deficiency, Maintenance, Tumors, Therapy, Recommendations, Identification, Chemotherapy, Cancers

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10138/565119; 85168221283; 001052127900001

الاتاحة: http://hdl.handle.net/10138/565119

المؤلفون: Pikkusaari, Sanna, Tumiati, Manuela, Virtanen, Anni, Oikkonen, Jaana, Li, Yilin, Perez-Villatoro, Fernando, Muranen, Taru, Salko, Matilda, Huhtinen, Kaisa, Kanerva, Anna, Koskela, Heidi, Tapper, Johanna, Koivisto-Korander, Riitta, Joutsiniemi, Titta, Haltia, Ulla-Maija, Lassus, Heini, Hautaniemi, Sampsa, Färkkilä, Anniina, Hynninen, Johanna, Hietanen, Sakari, Carpen, Olli, Kauppi, Liisa

المساهمون: Research Program in Systems Oncology, Tutkimusohjelmayksikkö, HUSLAB, Patologian osasto, Clinicum, HUS Naistentaudit ja synnykset, Akseli Eetu Hemminki / Vastuullinen tutkija, Naistenklinikka, Sampsa Hautaniemi / Vastuullinen tutkija, Tiedekunnan yhteiset (Lääketieteellinen tiedekunta), Bioinformatics, Biokemian ja kehitysbiologian osasto, Digital Precision Cancer Medicine (iCAN), Precision Cancer Pathology, Olli Mikael Carpen / Vastuullinen tutkija, HUS Diagnostiikkakeskus, Medicum, Tiedekunnan yhteiset (Bio- ja ympäristötieteellinen tiedekunta), Genome Stability Group

مصطلحات موضوعية: Somatic mutations, Double-blind, Platinum, Deficiency, Maintenance, Tumors, Therapy, Recommendations, Identification, Chemotherapy, Syöpätaudit

وصف الملف: application/pdf

Relation: Pikkusaari , S , Tumiati , M , Virtanen , A , Oikkonen , J , Li , Y , Perez-Villatoro , F , Muranen , T , Salko , M , Huhtinen , K , Kanerva , A , Koskela , H , Tapper , J , Koivisto-Korander , R , Joutsiniemi , T , Haltia , U-M , Lassus , H , Hautaniemi , S , Färkkilä , A , Hynninen , J , Hietanen , S , Carpen , O & Kauppi , L 2023 , ' Uusi työkalu räätälöityyn munasarjasyövän hoitoon ' , Duodecim , Vuosikerta. 139 , Nro 9 , Sivut 760 . < https://www.duodecimlehti.fi/duo17636 >; ORCID: /0000-0002-7749-2694/work/145922091; ORCID: /0000-0002-5895-1808/work/145922096; ORCID: /0000-0003-0598-5147/work/145925860; ORCID: /0000-0002-7467-8434/work/145927314; ORCID: /0000-0002-5419-8484/work/145927745; ORCID: /0000-0002-2966-0446/work/145927750; ORCID: /0000-0001-9685-5246/work/145927956; http://hdl.handle.net/10138/566708; 8369a77d-fcbe-47e2-b813-26199a0a90ab

الاتاحة: http://hdl.handle.net/10138/566708

المؤلفون: Basnet, Saru, Santos, Joao M., Quixabeira, Dafne C. A., Clubb, James H. A., Grönberg-Vähä-Koskela, Susanna A. M., Arias, Victor, Pakola, Santeri, Kudling, Tatiana V., Heiniö, Camilla, Havunen, Riikka, Cervera-Carrascon, Victor, Sorsa, Suvi, Anttila, Marjukka, Kanerva, Anna, Hemminki, Akseli

المساهمون: TRIMM - Translational Immunology Research Program, Research Programs Unit, HUS Helsinki and Uusimaa Hospital District, HUS Comprehensive Cancer Center, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Clinicum, Department of Obstetrics and Gynecology, Department of Oncology

مصطلحات موضوعية: Cancer, Therapy, Antibodies, Efficacy, Improves, Antigen, Marker, Cancers

وصف الملف: application/pdf

Relation: http://hdl.handle.net/10138/565407; 85146071632; 001058602600001

الاتاحة: http://hdl.handle.net/10138/565407

المؤلفون: Kanerva, Anna-Maria, Hokkanen, Tatu, Lehikoinen, Aleksi, Norrdahl, Kai, Suhonen, Jukka

المصدر: Oecologia, 2020 Aug 01. 193(4), 1021-1026.

URL الوصول: https://www.jstor.org/stable/48696179

المؤلفون: Hirvi-Ijäs, Maria, Kanerva, Anna

المصدر: The Impact of UNESCO on States' Cultural Policies ; page 99-131 ; ISBN 9781003462866

الاتاحة: http://dx.doi.org/10.4324/9781003462866-6

المؤلفون: Hemminki Kari, Kanerva Anna, Försti Asta, Hemminki Akseli

المصدر: BMC Cancer, 22(1), 1-10, (2022-04-26)

مصطلحات موضوعية: Incidence trends, Human papilloma virus, Risk factors, Age-specific incidence, Relative survival

Relation: oai:zenodo.org:7104748

الاتاحة: https://doi.org/10.1186/s12885-022-09582-5

المؤلفون: Hemminki, Kari, Kanerva, Anna, Försti, Asta, Hemminki, Akseli

المساهمون: Research Programs Unit, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Clinicum, Department of Obstetrics and Gynecology, Helsinki University Hospital Area, University of Helsinki, TRIMM - Translational Immunology Research Program, Department of Oncology, HUS Comprehensive Cancer Center

مصطلحات موضوعية: Cancers, Age-specific incidence, Human papilloma virus, Incidence trends, Relative survival, Risk factors, EXPERIENCES, REGISTRIES, RISKS, NON-ATTENDEES, END, AGE, Gynaecology and paediatrics

وصف الملف: application/pdf

Relation: Supported by the European Union’s Horizon 2020 research and innovation programme, grant No 856620 (Chaperon), Jane and Aatos Erkko Foundation, Finnish Cancer Organizations, University of Helsinki, Helsinki University Central Hospital, Novo Nordisk Foundation, Päivikki and Sakari Sohlberg Foundation. The funders had no role in this study.; Hemminki , K , Kanerva , A , Försti , A & Hemminki , A 2022 , ' Cervical, vaginal and vulvar cancer incidence and survival trends in Denmark, Finland, Norway and Sweden with implications to treatment ' , BMC Cancer , vol. 22 , no. 1 , 456 . https://doi.org/10.1186/s12885-022-09582-5; ORCID: /0000-0001-7103-8530/work/156151606; http://hdl.handle.net/10138/343558; 25b2fe56-89f5-4c81-8581-a8510dbc3745; 85128959776; 000787772900002

الاتاحة: http://hdl.handle.net/10138/343558

المؤلفون: Zafar, Sadia, Basnet, Saru, Launonen, Inga-Maria, Quixabeira, Dafne Carolina Alves, Santos, Joao, Hemminki, Otto, Malmstedt, Minna, Cervera-Carrascon, Victor, Aronen, Pasi, Kalliokoski, Riikka, Havunen, Riikka, Rannikko, Antti, Mirtti, Tuomas, Matikainen, Mika, Kanerva, Anna, Hemminki, Akseli

المساهمون: HUS Comprehensive Cancer Center, Department of Oncology, TRIMM - Translational Immunology Research Program, University of Helsinki, Research Programs Unit, Department of Pathology, Clinicum, HUS Helsinki and Uusimaa Hospital District, Medicum, HUS Abdominal Center, Urologian yksikkö, Department of Surgery, Helsinki University Hospital Area, Research Program in Systems Oncology, HUSLAB, University Management, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator

مصطلحات موضوعية: adenovirus 3, CD40 ligand, dendritic cells (DCs), prostate cancer, tumor microenvironment, PHASE-I, IMMUNE-RESPONSE, GENE-TRANSFER, DESMOGLEIN 2, IMMUNOTHERAPY, LIGAND, DIFFERENTIATION, PROGRESSION, VACCINATION, MECHANISMS, 11832 Microbiology and virology, Medical biotechnology, Genetics, developmental biology, physiology

وصف الملف: application/pdf

Relation: This study was supported by KLTO (Doctoral School for Clinical Research programme at the University of Helsinki), by Jane and Aatos Erkko Foundation, HUCH Research Funds (VTR), Sigrid Juselius Foundation, Finnish Cancer Organizations, University of Helsinki, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, and TILT Biotherapeutics Ltd. We thank Albert Ehrnrooth and Karl Fazer for research support.; Zafar , S , Basnet , S , Launonen , I-M , Quixabeira , D C A , Santos , J , Hemminki , O , Malmstedt , M , Cervera-Carrascon , V , Aronen , P , Kalliokoski , R , Havunen , R , Rannikko , A , Mirtti , T , Matikainen , M , Kanerva , A & Hemminki , A 2021 , ' Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples ' , Human Gene Therapy , vol. 32 , no. 3-4 , pp. 192-202 . https://doi.org/10.1089/hum.2020.222; ORCID: /0000-0003-0455-9891/work/91247092; ORCID: /0000-0002-4261-3484/work/91248374; ORCID: /0000-0001-7103-8530/work/156151591; http://hdl.handle.net/10138/339799; 2eaefc4a-dd1d-4bbf-a655-68da1e489798; 000613083700001

الاتاحة: http://hdl.handle.net/10138/339799

المؤلفون: Heiniö, Camilla, Clubb, James, Kudling, Tatiana, Quixabeira, Dafne, Cervera-Carrascon, Victor, Havunen, Riikka, Grönberg-Vähä-Koskela, Susanna, Santos, Joao Manuel, Tapper, Johanna, Kanerva, Anna, Hemminki, Akseli

المساهمون: TRIMM - Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Research Programs Unit, HUS Comprehensive Cancer Center, HUS Gynecology and Obstetrics, Department of Obstetrics and Gynecology, Clinicum, Akseli Eetu Hemminki / Principal Investigator, Department of Oncology

مصطلحات موضوعية: ovarian cancer, oncolytic virus, immune checkpoint inhibitor, adenovirus, TILT-123, NECROSIS-FACTOR-ALPHA, FOLLOW-UP, THERAPY, CELLS, Cancers, Biomedicine

وصف الملف: application/pdf

Relation: This study was supported by the doctoral programme in clinical research (University of Helsinki), Jane and Aatos Erkko Foundation, HUCH Research Funds (VTR), Finnish Cancer Organizations, University of Helsinki, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation, TILT Biotherapeutics Ltd. We thank Albert Ehrnrooth and Karl Fazer for research support. Also, we thank Minna Oksanen for expert assistance.; Heiniö , C , Clubb , J , Kudling , T , Quixabeira , D , Cervera-Carrascon , V , Havunen , R , Grönberg-Vähä-Koskela , S , Santos , J M , Tapper , J , Kanerva , A & Hemminki , A 2022 , ' Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers ' , Viruses (Basel) , vol. 10 , no. 3 , 52 . https://doi.org/10.3390/diseases10030052; ORCID: /0000-0001-7103-8530/work/156151552; http://hdl.handle.net/10138/352165; 7973e8da-9451-4ca0-8885-c62169c49084; 000859414600001

الاتاحة: http://hdl.handle.net/10138/352165

المؤلفون: Kudling, Tatiana V., Clubb, James H. A., Quixabeira, Dafne C. A., Santos, Joao M., Havunen, Riikka, Kononov, Alexander, Heiniö, Camilla, Cervera-Carrascon, Victor, Pakola, Santeri, Basnet, Saru, Grönberg-Vähä-Koskela, Susanna, Arias, Victor, Gladwyn-Ng, Ivan, Aro, Katri, Bäck, Leif, Räsänen, Jari, Ilonen, Ilkka, Borenius, Kristian, Räsänen, Mikko, Hemminki, Otto, Rannikko, Antti, Kanerva, Anna, Tapper, Johanna, Hemminki, Akseli

المساهمون: TRIMM - Translational Immunology Research Program, Research Programs Unit, HUS Comprehensive Cancer Center, Department of Oncology, HUS Head and Neck Center, Korva-, nenä- ja kurkkutautien klinikka, Clinicum, HUS Heart and Lung Center, III kirurgian klinikka, Department of Surgery, HUS Abdominal Center, Urologian yksikkö, HUS Gynecology and Obstetrics, Akseli Eetu Hemminki / Principal Investigator, Department of Obstetrics and Gynecology

مصطلحات موضوعية: Oncolytic virus, adenovirus, interleukin 7, immunotherapy, RESECTED CUTANEOUS MELANOMA, T-CELLS, IL-7, EXPANSION, CD8(+), EXPRESSION, MODEL, Cancers

وصف الملف: application/pdf

Relation: This study was supported by Doctoral programme in clinical research (University of Helsinki), Jane and Aatos Erkko Foundation, HUCH Research Funds (VTR), Finnish Cancer Organizations, Novo Nordisk Foundation, Paivikki and Sakari Sohlberg Foundation and TILT Biotherapeutics Ltd;Marie Sklodowska-Curie;Doctoral programme in clinical research, University of Helsinki, Finland;Suomen Kulttuurirahasto;TILT Biotherapeutics Ltd.; Kudling , T V , Clubb , J H A , Quixabeira , D C A , Santos , J M , Havunen , R , Kononov , A , Heiniö , C , Cervera-Carrascon , V , Pakola , S , Basnet , S , Grönberg-Vähä-Koskela , S , Arias , V , Gladwyn-Ng , I , Aro , K , Bäck , L , Räsänen , J , Ilonen , I , Borenius , K , Räsänen , M , Hemminki , O , Rannikko , A , Kanerva , A , Tapper , J & Hemminki , A 2022 , ' Local delivery of interleukin 7 with an oncolytic adenovirus activates tumor-infiltrating lymphocytes and causes tumor regression ' , OncoImmunology , vol. 11 , no. 1 , 2096572 . https://doi.org/10.1080/2162402X.2022.2096572; ORCID: /0000-0002-4261-3484/work/116551277; ORCID: /0000-0001-6235-8612/work/116554733; ORCID: /0000-0002-8149-3550/work/116555101; ORCID: /0000-0001-7103-8530/work/156151505; http://hdl.handle.net/10138/346497; 4ed7cb2f-6254-4f8e-8271-6cfe623ce91f; 000823264800001

الاتاحة: http://hdl.handle.net/10138/346497